FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Azithromycin for Suspension
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Pfizer Inc. (New 10/15/2024)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
Zithromax, for Suspension, 1 g (NDC 0069-3051-75)	03/26/2024	Discontinuation due to business reasons.
Zithromax, for Suspension, 1 g (NDC 59762-3051-1)	05/17/2024	Discontinuation of the manufacture of the drug.
Zithromax, for Suspension, 1 g (NDC 59762-3051-2)	05/17/2024	Discontinuation of the manufacture of the drug.
Zithromax, for Suspension, 200 mg/5 mL (NDC 59762-3120-1)	05/17/2024	Discontinuation of the manufacture of the drug.
Zithromax, for Suspension, 900 mg/22.5 mL (NDC 59762-3130-1)	05/17/2024	Discontinuation of the manufacture of the drug.
Zithromax, for Suspension, 1200 mg/30 mL (NDC 59762-3140-1)	05/17/2024	Discontinuation of the manufacture of the drug.
Zithromax, for Suspension, 100 mg/5 mL (NDC 59762-3110-1)	10/15/2024